BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8364369)

  • 1. Potentially malignant lesions and conditions of the mouth and oropharynx: natural history--cellular and molecular markers of risk.
    Johnson NW; Ranasinghe AW; Warnakulasuriya KA
    Eur J Cancer Prev; 1993 Jun; 2 Suppl 2():31-51. PubMed ID: 8364369
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative molecular and histological grading of epithelial dysplasia of the oral cavity and the oropharynx.
    Tabor MP; Braakhuis BJ; van der Wal JE; van Diest PJ; Leemans CR; Brakenhoff RH; Kummer JA
    J Pathol; 2003 Mar; 199(3):354-60. PubMed ID: 12579537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A tale of two cancers: carcinomas of the oral cavity and oropharynx.
    Myers JN; Sturgis EM
    Otolaryngol Clin North Am; 2013 Aug; 46(4):xiii-xvi. PubMed ID: 23910479
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening for oral potentially malignant epithelial lesions and squamous cell carcinoma: a discussion of benefit and risk.
    Epstein JB
    J Can Dent Assoc; 2014; 80():e47. PubMed ID: 25055237
    [No Abstract]   [Full Text] [Related]  

  • 5. Predicting progression of oral dysplasia--response.
    Rosin MP; Zhang L; Mao L
    Cancer Prev Res (Phila); 2013 Jun; 6(6):616. PubMed ID: 23592740
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiple head and neck tumors frequently originate from a single preneoplastic lesion.
    Tabor MP; Brakenhoff RH; Ruijter-Schippers HJ; Van Der Wal JE; Snow GB; Leemans CR; Braakhuis BJ
    Am J Pathol; 2002 Sep; 161(3):1051-60. PubMed ID: 12213734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implication for second primary cancer from visible oral and oropharyngeal premalignant lesions in betel-nut chewing related oral cancer.
    Liu SY; Feng IJ; Wu YW; Chen CY; Hsiung CN; Chang HW; Lin CY; Chang MT; Yu HC; Lee SY; Yen CY
    Head Neck; 2017 Jul; 39(7):1428-1435. PubMed ID: 28383824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive early diagnosis of oral cavity malignancies.
    Sudbø J
    Anal Cell Pathol; 2003; 25(4):157-8. PubMed ID: 14501081
    [No Abstract]   [Full Text] [Related]  

  • 9. Tissue markers of potentially malignant human oral epithelial lesions.
    Scully C; Burkhardt A
    J Oral Pathol Med; 1993 Jul; 22(6):246-56. PubMed ID: 8355223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral cancer: comprehending the condition, causes, controversies, control and consequences. 4. Potentially malignant disorders of the oral and oropharyngeal mucosa.
    van der Waal I; Scully C
    Dent Update; 2011 Mar; 38(2):138-40. PubMed ID: 21500626
    [No Abstract]   [Full Text] [Related]  

  • 11. [Early recognition of cancerous lesions in the mouth and oropharynx: Automated evaluation of hyperspectral image stacks].
    Laffers W; Westermann S; Regeling B; Martin R; Thies B; Gerstner AO; Bootz F; Müller NA
    HNO; 2016 Jan; 64(1):27-33. PubMed ID: 26676521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 expression in oral disease.
    Ogden GR
    Br J Oral Maxillofac Surg; 1993 Feb; 31(1):63. PubMed ID: 8431418
    [No Abstract]   [Full Text] [Related]  

  • 13. [Leukoplakia as a precancerous lesion of the oral cavity].
    Tana M; Cortellessa R; Giacomini G; Coletti C; Giacomini G
    Riv Ital Stomatol; 1984 Feb; 53(2):115-20. PubMed ID: 6591351
    [No Abstract]   [Full Text] [Related]  

  • 14. Epidemiology of cancer from the oral cavity and oropharynx.
    Lambert R; Sauvaget C; de Camargo Cancela M; Sankaranarayanan R
    Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):633-41. PubMed ID: 21654320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma.
    Girod SC; Pfeiffer P; Ries J; Pape HD
    Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Podoplanin and ABCG2: malignant transformation risk markers for oral lichen planus.
    Shi P; Liu W; Zhou ZT; He QB; Jiang WW
    Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):844-9. PubMed ID: 20200437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Precancerous lesions of the mouth: lichen planus and other processes].
    Bascones Martinez A
    Estodont Press; 1983; 1(2):11-20 concl. PubMed ID: 6578034
    [No Abstract]   [Full Text] [Related]  

  • 18. Gain of hTERC: a genetic marker of malignancy in oral potentially malignant lesions.
    Dorji T; Monti V; Fellegara G; Gabba S; Grazioli V; Repetti E; Marcialis C; Peluso S; Di Ruzza D; Neri F; Foschini MP
    Hum Pathol; 2015 Sep; 46(9):1275-81. PubMed ID: 26170010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early detection is critical for oral cancer patients.
    Kabani S; Dhingra JK
    J Mass Dent Soc; 1997; 46(1):41-3, 46-8. PubMed ID: 9540729
    [No Abstract]   [Full Text] [Related]  

  • 20. Exploring the link between human papilloma virus and oral and oropharyngeal cancers.
    Khode SR; Dwivedi RC; Rhys-Evans P; Kazi R
    J Cancer Res Ther; 2014; 10(3):492-8. PubMed ID: 25313727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.